From the Infection to the Immunotherapy in Cervical Cancer: Can We Stop the Natural Course of the Disease?

Cervical cancer (CC) is the second leading cause of cancer death in women aged 20–39 years. Persistent infection with oncogenic types of human papillomavirus (HPV) represents the most important risk factor for the development of cervical cancer. Three HPVs vaccines are currently on the global market...

Descripción completa

Detalles Bibliográficos
Autores principales: Luvero, Daniela, Lopez, Salvatore, Bogani, Giorgio, Raspagliesi, Francesco, Angioli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712259/
https://www.ncbi.nlm.nih.gov/pubmed/33050484
http://dx.doi.org/10.3390/vaccines8040597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712259/
https://www.ncbi.nlm.nih.gov/pubmed/33050484
http://dx.doi.org/10.3390/vaccines8040597

Ejemplares similares